tirzepatide type 1 diabetes trial monotherapy in Chinese patients with early 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) Tirzepatide as Adjunct to Insulin
Pay in 4 interest-free payments of $7.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2














:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)















